[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fw_D6RU46jpSHSBI0RD1Tu1ZM4vy3lE92gjeNfLmggk0":3},{"id":4,"source":5,"question":6,"options":7,"answer":12,"related":13,"type":119,"origin":120,"createTime":26},304545693,"v1","下列哪个文件出台,标志着我国人类遗传资源管理上升至国家法律层面( )",[8,9,10,11],"《人类遗传资源管理条例实施细则》","《中华人民共和国生物安全法》","《中华人民共和国人类遗传资源管理条例》","《人类遗传资源管理暂行办法》",[],[14,27,37,47,57,67,78,88,98,109],{"id":15,"source":5,"question":16,"options":17,"answer":22,"related":23,"type":24,"origin":25,"createTime":26},304545673,"规范化管理试验用药品的意义",[18,19,20,21],"确保项目正常进行","保障受试者安全","确保治疗效果","合理控制成本",[],[],1,null,"2026-01-06T14:11:36+08:00",{"id":28,"source":5,"question":29,"options":30,"answer":35,"related":36,"type":24,"origin":25,"createTime":26},304545674,"试验方案名称包含的信息有( )",[31,32,33,34],"适应证","试验用药品","试验目的","试验设计",[],[],{"id":38,"source":5,"question":39,"options":40,"answer":45,"related":46,"type":24,"origin":25,"createTime":26},304545675,"下列缩写与中文名称对应正确的有( )",[41,42,43,44],"GSP-----药品经营质量管理规范","GMP----药品生产质量管理规范","GCP---药物临床试验质量管理规范","GVP-----药物警戒质量管理规范",[],[],{"id":48,"source":5,"question":49,"options":50,"answer":55,"related":56,"type":24,"origin":25,"createTime":26},304545676,"知情同意的准则有( )",[51,52,53,54],"充分理解","书面签署","完全告知","自主选择",[],[],{"id":58,"source":5,"question":59,"options":60,"answer":65,"related":66,"type":24,"origin":25,"createTime":26},304545677,"下列属于研究者的职责的是( )",[61,62,63,64],"填写病例报告表","处理剩余的试验用药品","做出相关的医疗决定","报告不良事件",[],[],{"id":68,"source":5,"question":69,"options":70,"answer":76,"related":77,"type":24,"origin":25,"createTime":26},304545678,"关于CRA的职责,下述说法正确的是( )",[71,72,73,74,75],"参与病例报告表的填写","以谈话形式对受试者进行知情同意","保证临床试验按照试验方案、标准操作规程和相关法律法规要求实施、记录和报告","预约接待受试者","每次监查后,应当及时书面报告申办者",[],[],{"id":79,"source":5,"question":80,"options":81,"answer":86,"related":87,"type":24,"origin":25,"createTime":26},304545679,"以下需要伦理审查的项目有( )",[82,83,84,85],"研究者发起的临床研究","医疗器械临床试验","药物临床试验","新医疗新技术研究项目",[],[],{"id":89,"source":5,"question":90,"options":91,"answer":96,"related":97,"type":24,"origin":25,"createTime":26},304545680,"下列属于知情同意书必需的内容的是( )",[33,92,93,94,95],"研究资料的归档要求","参加该试验的预计受试者人数","研究者的专业资格和经验","试验预期的受益和可能发生的风险",[],[],{"id":99,"source":5,"question":100,"options":101,"answer":107,"related":108,"type":24,"origin":25,"createTime":26},304545681,"药物临床试验开展的流程包括( )",[102,103,104,105,106],"项目研讨会","项目设计","项目立项","项目结束","项目运行",[],[],{"id":110,"source":5,"question":111,"options":112,"answer":117,"related":118,"type":24,"origin":25,"createTime":26},304545682,"11岁学生参加临床试验签署知情同意书时注意( )",[113,114,115,116],"如果父母同意参加临床试验并签署,该学生不签署即可参加","如果该学生不愿意参加,父母也需要尊重其意见","需要学生和父母同时进行签署","已有阅读签署能力自行签署即可",[],[],0,{"courseName":121,"courseImg":122,"workName":123,"workId":124,"count":125,"courseId":126},"默认课程","https:\u002F\u002Fp.ananas.chaoxing.com\u002Fstar3\u002F240_130c\u002F3a7c4e2929905646967168696f78ff01.png","GCP检测","exam_168773854",70,"53e1d2ef4961cca8eea3e23969ad2cb9"]